Financhill
Sell
46

TRVI Quote, Financials, Valuation and Earnings

Last price:
$11.22
Seasonality move :
56.55%
Day range:
$10.94 - $11.75
52-week range:
$3.47 - $14.39
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
7.91x
Volume:
2.5M
Avg. volume:
2.1M
1-year change:
187.72%
Market cap:
$1.5B
Revenue:
--
EPS (TTM):
-$0.37
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue -- -- -- -- --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $47K $50K $43K $123K $147K
Gross Profit -$47K -$50K -$43K -$123K -$147K
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $22.3M $23M $19.9M $23.7M $39.4M
Selling, General & Admin $10.2M $9.5M $10.1M $10.2M $12.1M
Other Inc / (Exp) -$9K -$293K $142K $469K -$15K
Operating Expenses $32.4M $32.4M $29.9M $33.8M $51.4M
Operating Income -$32.5M -$32.5M -$29.9M -$33.9M -$51.5M
 
Net Interest Expenses $456K $1.2M $1.2M $391K $4K
EBT. Incl. Unusual Items -$32.8M -$34M -$29.2M -$29.1M -$47.9M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$18K -$21K -$72K -$32K -$30K
Net Income to Company -$32.8M -$33.9M -$29.2M -$29.1M -$47.9M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$32.8M -$33.9M -$29.2M -$29.1M -$47.9M
 
Basic EPS (Cont. Ops) -$1.81 -$1.49 -$0.45 -$0.29 -$0.47
Diluted EPS (Cont. Ops) -$1.81 -$1.49 -$0.45 -$0.29 -$0.47
Weighted Average Basic Share $18.1M $22.8M $64.5M $99M $102M
Weighted Average Diluted Share $18.1M $22.8M $64.5M $99M $102M
 
EBITDA -$32.4M -$32.4M -$29.9M -$33.8M -$51.4M
EBIT -$32.5M -$32.5M -$29.9M -$33.9M -$51.5M
 
Revenue (Reported) -- -- -- -- --
Operating Income (Reported) -$32.5M -$32.5M -$29.9M -$33.9M -$51.5M
Operating Income (Adjusted) -$32.5M -$32.5M -$29.9M -$33.9M -$51.5M
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Revenue -- -- -- -- --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $13K $9K $35K $36K $38K
Gross Profit -$13K -$9K -$35K -$36K -$38K
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $4.7M $5.8M $6.3M $11.2M $10.1M
Selling, General & Admin $2.2M $2.6M $2.7M $2.9M $3.8M
Other Inc / (Exp) -$5K -- $154K -$11K --
Operating Expenses $6.9M $8.4M $9M $14.1M $13.9M
Operating Income -$6.9M -$8.4M -$9M -$14.1M -$13.9M
 
Net Interest Expenses $303K $292K $3K $1K --
EBT. Incl. Unusual Items -$7.3M -$8.3M -$7.7M -$13.3M -$11.8M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $2K -$7K -$13K -$31K -$15K
Net Income to Company -$7.3M -$8.3M -$7.7M -$13.2M -$11.8M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$7.3M -$8.3M -$7.7M -$13.2M -$11.8M
 
Basic EPS (Cont. Ops) -$0.34 -$0.12 -$0.08 -$0.13 -$0.08
Diluted EPS (Cont. Ops) -$0.34 -$0.12 -$0.08 -$0.13 -$0.08
Weighted Average Basic Share $21.6M $68.9M $99.3M $101.3M $145.1M
Weighted Average Diluted Share $21.6M $68.9M $99.3M $101.3M $145.1M
 
EBITDA -$6.9M -$8.4M -$9M -$14.1M -$13.9M
EBIT -$6.9M -$8.4M -$9M -$14.1M -$13.9M
 
Revenue (Reported) -- -- -- -- --
Operating Income (Reported) -$6.9M -$8.4M -$9M -$14.1M -$13.9M
Operating Income (Adjusted) -$6.9M -$8.4M -$9M -$14.1M -$13.9M
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Revenue -- -- -- -- --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $51K $40K $103K $144K $151K
Gross Profit -$51K -$40K -$103K -$144K -$151K
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $23.4M $21.7M $21.5M $36.6M $36.6M
Selling, General & Admin $10M $9.8M $10.2M $11.6M $14.7M
Other Inc / (Exp) -$346K -$94K $761K -$20K --
Operating Expenses $33.3M $31.5M $31.5M $48.1M $51.2M
Operating Income -$33.4M -$31.5M -$31.6M -$48.2M -$51.4M
 
Net Interest Expenses $1.2M $1.2M $661K $7K $1K
EBT. Incl. Unusual Items -$34.9M -$32.2M -$26.8M -$44.3M -$45.9M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $2K -$21K -$70K -$29K -$31K
Net Income to Company -$34.9M -$32.2M -$26.7M -$44.3M -$45.9M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$34.9M -$32.2M -$26.7M -$44.3M -$45.9M
 
Basic EPS (Cont. Ops) -$1.77 -$0.79 -$0.27 -$0.44 -$0.37
Diluted EPS (Cont. Ops) -$1.77 -$0.79 -$0.27 -$0.44 -$0.37
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA -$33.3M -$31.5M -$31.5M -$48.1M -$51.2M
EBIT -$33.4M -$31.5M -$31.6M -$48.2M -$51.4M
 
Revenue (Reported) -- -- -- -- --
Operating Income (Reported) -$33.4M -$31.5M -$31.6M -$48.2M -$51.4M
Operating Income (Adjusted) -$33.4M -$31.5M -$31.6M -$48.2M -$51.4M
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Revenue -- -- -- -- --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $38K $28K $88K $109K $113K
Gross Profit -$38K -$28K -$88K -$109K -$113K
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $16.8M $15.5M $17.2M $30M $27.3M
Selling, General & Admin $7.4M $7.7M $7.8M $9.2M $11.8M
Other Inc / (Exp) -$346K -$147K $472K -$17K -$6K
Operating Expenses $24.2M $23.2M $24.9M $39.2M $39M
Operating Income -$24.2M -$23.3M -$25M -$39.3M -$39.1M
 
Net Interest Expenses $893K $889K $387K $3K --
EBT. Incl. Unusual Items -$25.4M -$23.7M -$21.3M -$36.5M -$34.5M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$15K -$16K -$50K -$47K -$47K
Net Income to Company -$25.4M -$23.6M -$21.2M -$36.5M -$34.4M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$25.4M -$23.6M -$21.2M -$36.5M -$34.4M
 
Basic EPS (Cont. Ops) -$1.25 -$0.49 -$0.21 -$0.36 -$0.26
Diluted EPS (Cont. Ops) -$1.25 -$0.49 -$0.21 -$0.36 -$0.26
Weighted Average Basic Share $61.1M $159.2M $296.6M $301.8M $393.1M
Weighted Average Diluted Share $61.1M $159.2M $296.6M $301.8M $393.1M
 
EBITDA -$24.2M -$23.2M -$24.9M -$39.2M -$39M
EBIT -$24.2M -$23.3M -$25M -$39.3M -$39.1M
 
Revenue (Reported) -- -- -- -- --
Operating Income (Reported) -$24.2M -$23.3M -$25M -$39.3M -$39.1M
Operating Income (Adjusted) -$24.2M -$23.3M -$25M -$39.3M -$39.1M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $45M $36.8M $120.5M $83M $107.6M
Short Term Investments -- -- $107.9M $50.6M $73.5M
Accounts Receivable, Net -- -- -- -- --
Inventory -- -- -- -- --
Prepaid Expenses $1M $886K $795K $3.6M $407K
Other Current Assets -- $241K $1.3M $955K $867K
Total Current Assets $46.3M $38M $122.6M $87.5M $109.4M
 
Property Plant And Equipment $330K $184K $194K $1.6M $1.2M
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $532K $334K $205K $297K $243K
Total Assets $47.1M $38.5M $123M $89.4M $110.9M
 
Accounts Payable $2M $2.8M $2.9M $1.8M $3.4M
Accrued Expenses $2.5M $2.6M $2M $2.1M $4.3M
Current Portion Of Long-Term Debt -- $5.8M $7M -- --
Current Portion Of Capital Lease Obligations $113K $120K $25K $306K $285K
Other Current Liabilities -- $114K -- -- --
Total Current Liabilities $5.6M $12.7M $13.4M $5.8M $10.5M
 
Long-Term Debt $14.3M $8.7M $2.2M $1M $747K
Capital Leases -- -- -- -- --
Total Liabilities $19.8M $21.4M $15.6M $6.9M $11.3M
 
Common Stock $19K $29K $60K $68K $94K
Other Common Equity Adj -- -- -$122K -$29K $61K
Common Equity $27.3M $17.1M $107.5M $82.5M $99.6M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $27.3M $17.1M $107.5M $82.5M $99.6M
 
Total Liabilities and Equity $47.1M $38.5M $123M $89.4M $110.9M
Cash and Short Terms $45M $36.8M $120.5M $83M $107.6M
Total Debt $14.3M $14.6M $9.2M $1.2M $778K
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Cash and Equivalents $29.3M $125.6M $88.9M $65.5M $194.9M
Short Term Investments -- $59M $62.9M $49.4M --
Accounts Receivable, Net -- -- -- -- --
Inventory -- -- -- -- --
Prepaid Expenses $1.2M $1.3M $4M $1.2M $1.4M
Other Current Assets -- $421K $1M $667K --
Total Current Assets $30.7M $127.3M $94M $67.3M $198.3M
 
Property Plant And Equipment $222K $121K $1.6M $1.3M $954K
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets -- $922K $297K $256K --
Total Assets $31.6M $128.4M $95.9M $68.9M $199.4M
 
Accounts Payable $2.2M $2.3M $1.3M $1.6M $2.7M
Accrued Expenses $2.4M $4.2M $2.4M $5.4M --
Current Portion Of Long-Term Debt $4.1M $7M -- -- --
Current Portion Of Capital Lease Obligations $116K $59K $292K $297K --
Other Current Liabilities $167K -- -- -- --
Total Current Liabilities $9.9M $14.6M $5.2M $9.1M $9M
 
Long-Term Debt $10.3M $3.8M $1.1M $816K $527K
Capital Leases -- -- -- -- --
Total Liabilities $20.2M $18.5M $6.3M $9.9M $9.6M
 
Common Stock $22K $58K $64K $75K $128K
Other Common Equity Adj -- -$263K -$217K $139K --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $11.4M $109.9M $89.6M $59M $189.8M
 
Total Liabilities and Equity $31.6M $128.4M $95.9M $68.9M $199.4M
Cash and Short Terms $29.3M $125.6M $88.9M $65.5M $194.9M
Total Debt $14.6M $10.8M $1.2M $878K $527K
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders -$32.8M -$33.9M -$29.2M -$29.1M -$47.9M
Depreciation & Amoritzation $47K $50K $43K $123K $147K
Stock-Based Compensation $2.4M $2.5M $2.3M $2.2M $3.6M
Change in Accounts Receivable $293K -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -$29M -$28.9M -$28.2M -$31.7M -$38.3M
 
Capital Expenditures $32K -- $159K $137K $35K
Cash Acquisitions -- -- -- -- --
Cash From Investing -$32K -- -$107.4M $59.4M -$21.5M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued $14M -- -- -- --
Long-Term Debt Repaid -- -- -$5.8M -$9.5M -$126K
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$461K -$450K -$247K -$258K --
Cash From Financing $16.7M $20.8M $111.3M -$7.9M $61.5M
 
Beginning Cash (CF) $45M $36.8M $12.6M $32.4M $34.1M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$12.3M -$8.2M -$24.2M $19.8M $1.7M
Ending Cash (CF) $32.7M $28.7M -$11.7M $52.2M $35.8M
 
Levered Free Cash Flow -$29M -$28.9M -$28.3M -$31.8M -$38.3M
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Net Income to Stockholders -$7.3M -$8.3M -$7.7M -$13.2M -$11.8M
Depreciation & Amoritzation $13K $9K $35K $36K $38K
Stock-Based Compensation $540K $569K $530K $821K $1.2M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -$7.2M -$8.6M -$7.3M -$9.6M -$10.9M
 
Capital Expenditures -- $43K $18K -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -$4.9M $18M $7.7M -$50.9M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -$1.8M -$31K -$32K --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$399K -$161K -$172K -- --
Cash From Financing $134K $55.3M $1.5M $5M $1.6M
 
Beginning Cash (CF) $29.3M $66.6M $26M $16.1M $56.9M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$7.1M $41.9M $12.2M $3.1M -$60.2M
Ending Cash (CF) $22.2M $108.5M $38.2M $19.1M -$3.3M
 
Levered Free Cash Flow -$7.2M -$8.6M -$7.3M -$9.6M -$10.9M
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Net Income to Stockholders -$34.9M -$32.2M -$26.7M -$44.3M -$45.9M
Depreciation & Amoritzation $51K $40K $103K $144K $151K
Stock-Based Compensation $2.5M $2.4M $2.2M $3.2M $4.8M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -$31.6M -$28.1M -$31.7M -$35.1M -$44M
 
Capital Expenditures $5K $43K $231K $50K $7K
Cash Acquisitions -- -- -- -- --
Cash From Investing -$5K -$59.1M -$1.7M $15.2M -$87.4M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -$4.1M -$11.2M -$127K --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$553K -$178K -$231K -- --
Cash From Financing $7.7M $124.4M -$7.2M $10M $172.2M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$24M $37.3M -$40.6M -$9.9M $40.8M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -$31.6M -$28.1M -$31.9M -$35.1M -$44M
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Net Income to Stockholders -$25.4M -$23.6M -$21.2M -$36.5M -$34.4M
Depreciation & Amoritzation $38K $28K $88K $109K $113K
Stock-Based Compensation $2M $1.8M $1.7M $2.7M $3.8M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -$22.7M -$21.8M -$25.4M -$28.7M -$34.5M
 
Capital Expenditures -- $43K $115K $28K --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -$59.1M $46.6M $2.3M -$63.5M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -$4.1M -$9.5M -$95K -$11K
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$488K -$216K -$200K -- -$222K
Cash From Financing $7M $110.7M -$7.9M $10M $120.7M
 
Beginning Cash (CF) $107.3M $120.4M $51.4M $42.8M $193.3M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$15.7M $29.7M $13.4M -$16.3M $22.8M
Ending Cash (CF) $91.6M $150.1M $64.7M $26.5M $216.1M
 
Levered Free Cash Flow -$22.7M -$21.9M -$25.5M -$28.7M -$34.5M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did Stan Druckenmiller Sell Broadcom Stock?
Why Did Stan Druckenmiller Sell Broadcom Stock?

In Q3, legendary macro investor Stan Druckenmiller sold his entire…

Why Is CoreWeave Stock Down So Much?
Why Is CoreWeave Stock Down So Much?

AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…

Why Did Stan Druckenmiller Buy MercadoLibre Stock?
Why Did Stan Druckenmiller Buy MercadoLibre Stock?

In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
65
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Buy
51
Is GOOGL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Buy
70
RGC alert for Jan 8

Regencell Bioscience Holdings Ltd. [RGC] is down 21.5% over the past day.

Buy
64
RVMD alert for Jan 8

Revolution Medicines, Inc. [RVMD] is up 4.61% over the past day.

Sell
38
CRNX alert for Jan 8

Crinetics Pharmaceuticals, Inc. [CRNX] is down 0.23% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock